Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Dow
Medtronic
Moodys
Boehringer Ingelheim

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Superpharm Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for SUPERPHARM, and what generic and branded alternatives to SUPERPHARM drugs are available?

SUPERPHARM has eighty-eight approved drugs.



Summary for Superpharm
US Patents:0
Tradenames:44
Ingredients:43
NDAs:88

Drugs and US Patents for Superpharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Superpharm INDOMETHACIN indomethacin CAPSULE;ORAL 070488-001 Oct 10, 1986 DISCN No No   Start Trial   Start Trial
Superpharm PREDNISONE prednisone TABLET;ORAL 088867-001 Oct 25, 1984 DISCN No No   Start Trial   Start Trial
Superpharm ACETAMINOPHEN AND CODEINE PHOSPHATE acetaminophen; codeine phosphate TABLET;ORAL 089183-001 Oct 18, 1985 DISCN No No   Start Trial   Start Trial
Superpharm SULFATRIM-DS sulfamethoxazole; trimethoprim TABLET;ORAL 070066-001 Jun 24, 1985 DISCN No No   Start Trial   Start Trial
Superpharm INDOMETHACIN indomethacin CAPSULE;ORAL 070487-001 Oct 10, 1986 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Harvard Business School
Colorcon
McKinsey
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.